• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[癌症研究中生存概率的年龄校正]

[The age correction of survival probabilities in cancer studies].

作者信息

Martus P, Birkenhake S, Sauer R

机构信息

Institut für Medizinische Statistik und Dokumentation, Universität Erlangen-Nürnberg.

出版信息

Strahlenther Onkol. 1998 Jan;174(1):1-6. doi: 10.1007/BF03038220.

DOI:10.1007/BF03038220
PMID:9463557
Abstract

PURPOSE

Survival of elder oncological patients may depend on the tumor disease, on reasons not related to the underlying disease or simply on patient's age. Therefore patient' age has to be taken into account if the objective of an oncological study is the disease-related survival. Basically, there are 3 different approaches: multivariate statistical modelling, estimation of disease-related survival after censoring of cases with cause of death not due to the tumor disease, and consideration of demographical data in the general population.

PATIENTS AND METHODS

Our paper deals with the age correction using the data from the 1986/88 census in Germany. We have written a computer program based on SPSSWIN, which allows an automated age correction. Using clinical data of radiotherapy after surgical therapy of bladder cancer, we illustrate the method.

RESULTS

The estimated 5-year-survival using the age correction was--dependent on patient's age in the sample--10% up to 15% higher than the uncorrected rate. In the whole sample of 333 unselected patients, 5-year-survival was corrected from 47% to 59%. In the normal population adjusted for age- and sex-distribution, the expected survival rate was 80%.

CONCLUSIONS

The age correction has substantial influence on survival analysis of male patients elder than 60 years and female patients elder than 70 years. It should therefore be used in oncological studies investigating long-term survival of patients in these age-groups.

摘要

目的

老年肿瘤患者的生存情况可能取决于肿瘤疾病本身、与基础疾病无关的因素或者仅仅取决于患者年龄。因此,如果肿瘤学研究的目标是疾病相关生存率,就必须考虑患者年龄。基本上有三种不同的方法:多变量统计建模、对死因并非肿瘤疾病的病例进行删失后估计疾病相关生存率,以及考虑一般人群的人口统计学数据。

患者与方法

我们的论文利用德国1986/88年人口普查数据进行年龄校正。我们编写了一个基于SPSSWIN的计算机程序,可实现自动年龄校正。我们以膀胱癌手术治疗后放疗的临床数据为例来说明该方法。

结果

使用年龄校正后的估计5年生存率——取决于样本中的患者年龄——比未校正率高10%至15%。在333例未经过筛选的患者的整个样本中,5年生存率从47%校正至59%。在根据年龄和性别分布进行调整的正常人群中,预期生存率为80%。

结论

年龄校正对60岁以上男性患者和70岁以上女性患者的生存分析有重大影响。因此,在研究这些年龄组患者长期生存情况的肿瘤学研究中应采用年龄校正。

相似文献

1
[The age correction of survival probabilities in cancer studies].[癌症研究中生存概率的年龄校正]
Strahlenther Onkol. 1998 Jan;174(1):1-6. doi: 10.1007/BF03038220.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
[Survival chances of Hungarian cancer patients in the National Cancer Registry].[匈牙利国家癌症登记处中癌症患者的生存几率]
Magy Onkol. 2008 Dec;52(4):339-49. doi: 10.1556/MOnkol.52.2008.4.2.
4
Assessing changes in the impact of cancer on population survival without considering cause of death.在不考虑死亡原因的情况下评估癌症对人群生存影响的变化。
J Natl Cancer Inst. 1997 Jan 1;89(1):58-65. doi: 10.1093/jnci/89.1.58.
5
A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.约克郡根治性膀胱切除术和根治性放疗治疗浸润性膀胱癌后的发病率、死亡率及长期生存率研究。
Eur Urol. 2003 Mar;43(3):246-57. doi: 10.1016/s0302-2838(02)00581-x.
6
Cancer survival in five continents: a worldwide population-based study (CONCORD).五大洲的癌症生存率:一项基于全球人群的研究(CONCORD)
Lancet Oncol. 2008 Aug;9(8):730-56. doi: 10.1016/S1470-2045(08)70179-7. Epub 2008 Jul 17.
7
Adjusting relative survival estimates for cancer mortality in the general population.调整一般人群中癌症死亡率的相对生存率估计。
Health Rep. 2014 Nov;25(11):3-9.
8
Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.葡萄膜黑色素瘤患者生存中的性别差异:韩国女性生存率高于男性。
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1909-1915. doi: 10.1167/iovs.16-20077.
9
Survival chance in papillary thyroid cancer in Hungary: individual survival probability estimation using the Markov method.
Radiother Oncol. 1997 Sep;44(3):203-12. doi: 10.1016/s0167-8140(97)00098-4.
10
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.

引用本文的文献

1
[Social gradient of PSA screening? 8 years follow up from the cancer registry of the tumor center in Regensburg].[前列腺特异性抗原(PSA)筛查的社会梯度?来自雷根斯堡肿瘤中心癌症登记处的8年随访]
Urologe A. 2010 Dec;49(12):1503-7. doi: 10.1007/s00120-010-2425-2.
2
[Surviving is not equal to survival?].[存活不等于生存?]
Med Klin (Munich). 1999 Apr 15;94 Suppl 2:10-3. doi: 10.1007/BF03042019.
3
Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer.

本文引用的文献

1
Maximum utilization of the life table method in analyzing survival.在分析生存情况时最大限度地利用生命表法。
J Chronic Dis. 1958 Dec;8(6):699-712. doi: 10.1016/0021-9681(58)90126-7.
2
Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.与单纯放疗相比,铂类衍生物同步放化疗在膀胱癌保器官治疗中的疗效。
Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):121-7. doi: 10.1016/s0360-3016(97)00579-8.
3
Long term survival analysis: the curability of breast cancer.长期生存分析:乳腺癌的可治愈性
经尿道膀胱切除术后单纯放疗或联合铂类衍生物进行放化疗。膀胱癌治疗后的器官保留及生存率。
Strahlenther Onkol. 1998 Mar;174(3):121-7. doi: 10.1007/BF03038494.
Stat Med. 1982 Apr-Jun;1(2):93-104. doi: 10.1002/sim.4780010202.
4
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.癌症研究中的统计方法。第二卷——队列研究的设计与分析。
IARC Sci Publ. 1987(82):1-406.
5
A method for analyzing mortality data collected in follow-up studies.一种分析随访研究中收集的死亡率数据的方法。
Methods Inf Med. 1978 Apr;17(2):116-20.